N-(2-Hydroxyethyl)Stearamide
CAS 111-57-9
N-(2-Hydroxyethyl)Stearamide (CAS 111-57-9) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 127.47999999999999 ug.mL-1 | 5 | - |
| - | IC50 | 10000 nM | 2 | - |
| - | Ki | 217 nM | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| GPR119 GPR119 |
Full agonist | - | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is N-(2-Hydroxyethyl)Stearamide used for in pharmaceutical contexts?
N-(2-Hydroxyethyl)Stearamide (CAS 111-57-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for N-(2-Hydroxyethyl)Stearamide?
No adverse-event association or SIDER side-effect rows are rendered for N-(2-Hydroxyethyl)Stearamide in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is N-(2-Hydroxyethyl)Stearamide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for STEARAMIDE MEA with EU status "permitted".
What clinical phase is N-(2-Hydroxyethyl)Stearamide in?
No phase 1-4 clinical development badge is rendered for N-(2-Hydroxyethyl)Stearamide because the matched compound identifier rows do not contain a max-phase value.